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Introduction
Parkinson’s Disease (PD)
➔
➔
➔
➔

Common neurodegenerative disorder affecting 2% of the population over 60
Characterized by a loss of dopaminergic neurons in the substantia nigra, increases in Lewy
bodies (ɑ-synuclein aggregates)
Results in a variety of motor control issues
Specific cause is unknown, likely genetic and environmental factors

Pathologies:
➔
Mitochondrial and autophagic dysfunction
➔
Oxidative stress
➔
Neuroinflammation
Physical symptoms:
➔
Tremors
➔
Balance issues
➔
Slow movements
➔
Muscle rigidity

Current Treatments
Levodopa (L-DOPA)
➔ Improves dopamine levels
➔ Initially alleviates symptoms such as Bradykinesia (slowed-movements)
➔ Long-term usage causes permanent motor deficits
Natural Health Products (NHPs)
➔ Found to possess neuroprotective properties to alleviate symptoms and prevent progression
➔ May avoid negative side effects associated with current treatments
○
Ubisol-Q10
○
Ashwagandha Root Extract

Ubisol-Q10
➔
➔
➔

Water-soluble formulation of Coenzyme-Q10 made using polyoxyethanyl-⍺-tocopheryl sebacate (PTS)
Increased bioavailability
Reduced dosages to achieve neuroprotection

Previous research with Ubisol-Q10 show:
➔ Antioxidant and anti-inflammatory properties
➔ Activator of astroglia and autophagy
➔ Prevents against senescence and mitochondrial dysfunction

Ashwagandha Root Extract (Withania Somnifera)
➔
➔
➔

Used in traditional Indian medicine
Naturally lipophilic
Water soluble formulation was created similar to Ubisol-Q10

Thought to possess many neuroprotective properties:
➔ Improved mitochondrial function
➔ Anti-inflammatory properties
➔ Increased dendrite formation

Research Question and Objectives
Research Question
Can the combination of water-soluble Ashwagandha root extract and Ubisol-Q10 exhibit
neuroprotective properties when used as treatment for Parkinson's Disease?

Objectives
1.

To compare the neuroprotective properties of water-soluble Ashwagandha and Ubisol-Q10 with treatment and
control groups.

2.

To evaluate the preservation of dopaminergic neurons in the substantia nigra after treatment with water-soluble
Ashwagandha and Ubisol-Q10 through the use of fluorescent staining techniques and the tyrosine hydroxylase
antibody.

3.

To study the effects of the NHPs on the mechanisms implicated by the progression of the disease including
autophagy, oxidative stress, senescence, and inflammation.

4.

To analyze the impact of the water-soluble Ashwagandha and Ubisol-Q10 treatment on the expression of
pro-survival neurotrophic factors by immunofluorescent staining of the antibodies BDNF, GDNF, and GFAP.

Methods
Rat Model Preparation
5 Treatment groups:
➔
Saline + Water control
➔
PQ + PTS control
➔
PQ + Water-Soluble Ashwagandha Root Extract
➔
PQ + Ubisol-Q10
➔
PQ + Tonic (Combination treatment of WS-Ashwagandha + Ubisol-Q10)
Paraquat (PQ) Injections
➔
Used to induce PD in rat models
◆
5 injections of 10 mg/kg body weight
◆
1 injection every 5 days for 25 days
Behavioural Testing + Sacrifice
Preservation of Brain Tissue
➔
Whole animal perfusion fixation technique

Methods
Brain Tissue Sectioning + Slide Preparation
Cryoprotection of Brain:
➔
30% sucrose solution submersion
Embedding Matrix + Vacuum Chamber
➔
Cerebellum and brainstem removed
Tissue Mounting:
➔
Matrix
Tissue Sectioning:
➔
Cryostat
➔
30μm at substantia nigra
3 sections/slide

Methods
Stereological Analysis + Immunofluorescent Staining
Immunofluorescent Staining and Microscopic Imaging
➔
Staining with primary and secondary antibodies
Evaluated:
➔
Oxidative stress
➔
Autophagy
➔
Inflammation
➔
Activation of neurotrophic growth factors (NGFs)

Results

Results

Results

Summary
- Neuroprotection of dopaminergic neurons in the substantia nigra
- Increased activation of Nerve Growth Factor
- Up-regulation of autophagy mechanisms
- Increased activation of pro-survival astroglial cells

Future Directions
- Quantitative analysis of TH positive neurons in the substantia nigra region
using a stereologer
- Evaluate activation of pro-survival neurotrophic factors by immunofluorescent
staining of BDNF and GDNF
- Evaluate oxidative stress and senescence in PTS and treatment groups using
4-HNE and p21 antibodies
- Clinical investigation using water-soluble Ashwagandha and Ubisol-Q10
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